STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
PHASE3CompletedINTERVENTIONAL
Enrollment
210
Participants
Timeline
Start Date
July 31, 2014
Primary Completion Date
July 31, 2022
Study Completion Date
July 1, 2024
Conditions
Multiple Myeloma
Interventions
DRUG
Lenalidomide
DRUG
Dexamethasone
Trial Locations (1)
10126
Fondazione EMN Italy Onlus, Torino
All Listed Sponsors
lead
Fondazione EMN Italy Onlus
OTHER
NCT02215980 - STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS | Biotech Hunter | Biotech Hunter